Otonomy Appoints Jill Broadfoot to Board of Directors

Back to Jobs

SAN DIEGO , Aug. 19, 2021 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the appointment of Jill Broadfoot to its board of directors.

Apply Now